Product Information
DOCUSATE SODIUM 100 MG SOFTGEL is a generic product labeled by Major Pharmaceuticals, priced at $0.0276 per EA under NDC 00904718361. Its NADAC has been published 237 times since Mar 23, 2022.
The High Outlier badge above means this manufacturer's average price in the Docusate Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904718361
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOCUSATE SODIUMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
9/4/2021
Price Statistics
The NADAC for DOCUSATE SODIUM 100 MG SOFTGEL has been published 237 times since Mar 23, 2022, and over the history we have for it it has risen 30.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0276 per EA |
|---|---|
| All-time high | $0.0321 (Jun 14, 2023) |
| All-time low | $0.0195 (Jun 22, 2022) |
| 52-week high | $0.0300 |
| 52-week low | $0.0272 |
| Median price | $0.0257 |
| Average price | $0.0253 |
| Largest weekly change | +37.8% (May 17, 2023) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Docusate Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOCUSATE SODIUM 100 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for DOCUSATE SODIUM 100 MG SOFTGEL, manufactured by Major Pharmaceuticals, is $0.0276 per EA (NDC 00904718361), effective Sep 30, 2026.
How has the price of DOCUSATE SODIUM 100 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for DOCUSATE SODIUM 100 MG SOFTGEL has risen 30.7%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for DOCUSATE SODIUM 100 MG SOFTGEL?
Since Mar 23, 2022, the NADAC for DOCUSATE SODIUM 100 MG SOFTGEL has ranged from a low of $0.0195 (Jun 22, 2022) to a high of $0.0321 (Jun 14, 2023), with a median of $0.0257 per EA.
Are there cheaper alternatives to DOCUSATE SODIUM 100 MG SOFTGEL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOCUSATE SODIUM 100 MG SOFTGEL in a comparable dosage form, but none are currently priced below it.
Who manufactures DOCUSATE SODIUM 100 MG SOFTGEL?
DOCUSATE SODIUM 100 MG SOFTGEL (NDC 00904718361) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.